Health Care Technology
Company Overview of Verix, Inc.
Verix, Inc. provides cloud-based analytical solutions to streamline commercial operations in the pharmaceutical industry. It offers Drug Launch application to measure the success of new drug launches at various stages; Pre-call Planning application to optimize sales calls; Patient Tracker application to aggregate various treatment related information in one solution; Managed Markets application for the account management business process; and Funnel Management application for medical devices, which enables managers to tackle their pipeline head-on so they can identify and course-correct issues. The company also provides Salesforce Effectiveness application that enables users to focus sales e...
339 South San Antonio Road
Los Altos, CA 94022
Founded in 2004
Key Executives for Verix, Inc.
Chief Executive Officer, President and Director
Co-Founder and Vice President of Reserach & Development
World Wide Vice President of Sales
Compensation as of Fiscal Year 2016.
Verix, Inc. Key Developments
Verix Appoints Nick Randazzo as World Wide Vice President of Sales
May 11 16
Verix announced the appointment of Nick Randazzo to the position of World Wide Vice President of Sales. Mr. Randazzo assumes responsibility for overall sales growth and sales strategies for the company’s rapidly growing business of analytic solutions for a wide range of commercial operations. Mr. Randazzo most recently served as Vice President of Global Sales for PHT Corporation.
Verix Appoints Duncan Lamb to the Advisory Board
Aug 5 15
Verix announced that Duncan Lamb will lead the Advisory Board efforts to provide advice and guidance to the company in a variety of business areas focusing mainly on the life sciences market. As Verix continues to expand its customer base, Duncan will be focusing on organizational and market excellence. Duncan has over 30 years' experience in the pharmaceutical business with Beecham Inc, Berlex Laboratories, Schering Ag and Bayer Healthcare Pharmaceuticals. Prior to announcing his retirement, he was a member of the Executive Committee responsible for managing the US pharmaceutical business for Bayer. As Vice President Business Intelligence, Development and Innovation, he led centers of excellence in functions that support sales and marketing, business development and strategy for all pharmaceutical brands in the USA.
Verix Appoints Mark Degatano to the Advisory Board
Jul 15 15
Verix announced the appointment of Mark Degatano to advisory board. Mark brings a wealth of Pharma commercial operations expertise and will play a key role as Verix continues executing its vision of optimizing business operations effectiveness in the Life Sciences industry. Mark Degatano has over 30 years of business operations experience in Pharma. As Vice President of Customer Insights at Merck, he directed the market research, business analytics, and sales force analytics teams. Previously, he was Chief Strategy Officer at ImpactRx and was a key member of the Symphony Technology team responsible for acquiring Source Health Analytics from Wolter's Kluwer Health and creating Symphony Health Solutions.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create
or control the content. For inquiries, please contact Capital IQ directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries